Medasense Biometrics Ltd.

Medasense Biometrics Ltd. is a medical technology company dedicated to improving pain management through its innovative NOL® (Nociception Level) technology. This noninvasive sensor platform utilizes artificial intelligence to objectively quantify pain responses, allowing clinicians to tailor pain treatment and optimize patient care while minimizing the risk of overmedication. The company's flagship product, the PMD-200™, is designed for use in critical care and anesthesia settings. It visualizes pain responses in real time, supporting healthcare professionals in making informed decisions about pain management. Medasense also offers clinical resources to assist in the effective implementation of their technology. With multiple patents in physiological monitoring and pain assessment, Medasense is committed to advancing innovation in this vital area of healthcare. Medasense serves healthcare professionals and institutions globally, including partnerships with major medical companies. Their solutions aim to enhance patient outcomes and reduce healthcare costs, addressing the significant challenges posed by pain management in clinical settings.

• Employees 27
• Founded 2008
• Annual Revenue $2000000
• Total Funding $31000000